Virginia Retirement System’s BioMarin Pharmaceuticals BMRN Stock Holding History

Virginia Retirement System’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$216K	Buy	+2,615	New	+$213K	﹤0.01%	951

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Virginia Retirement System's BMRN Position: Q1 2016 in Review

Virginia Retirement System opened a new position in BioMarin Pharmaceuticals (BMRN) in Q1 2016: 2,615 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #951 among its holdings.

390 funds tracked by Wall St. Rank hold BMRN as of Q1 2016.

Virginia Retirement System held 2,615 shares of BioMarin Pharmaceuticals worth $216K as of Q1 2016.
BioMarin Pharmaceuticals was a new Virginia Retirement System position in Q1 2016.
BioMarin Pharmaceuticals made up ﹤0.01% of Virginia Retirement System's portfolio in Q1 2016, its #951 holding.
390 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.